drugset / Trial / NCT07075783
The Efficacy and Safety of Magnesium Sulphate Adjuvant in Scalp Block With Ropivacaine for Supratentorial Craniotomy: a Prospective, Randomized Controlled Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized, double-blinded controlled trial was conducted to evaluate the analgesic efficacy of MgSO4 as an adjuvant to ropivacaine in scalp blocks for craniotomy, focusing on its impact on hemodynamic parameters and intraoperative remifentanil consumption.
Timeline
- Start
- 2024-10-03
- Primary completion
- 2025-04-15
- Completion
- 2025-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 50 % | Other |
| Background | Epinephrine | Other / unclassified | 5 ug/ml | Other |
| Background | Ropivacaine | Other / unclassified | 0.375 % | Other |
Indications
No indication recorded.